News

You are here

Home » News

Novosanis signs agreement with MDxHealth

23/03/2017
Novosanis develops UrNCollect TM for SelectMDx for Prostate Cancer IVD kit of MDxHealth
Read more

Novosanis’ medical device Colli-Pee™ has been approved for sales in the US by FDA

15/11/2016
Approval of Colli-Pee for commercial use in the US
Read more

First CE marked HPV test offering possibility to use first-void urine

31/10/2016
Novosanis, a medical device company based in Wijnegem Belgium, together with GeneFirst, a molecular diagnostic company based in Oxfordshire UK, announced CE Marking and launch of...
Read more

Novosanis attending Life Sciences week and BioJapan

12/10/2016
Novosanis will present its VAX-ID™ device platform during BioJapan
Read more

Pages